Cargando…
Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling
BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the cancers with the highest morbidity and mortality among the world. Studies have shown that the invasion and metastasis of tumor are biological characteristics of lung cancer, and also the main cause of treatment failure and patient death. I...
Autores principales: | Li, Fang, Chen, Hengchi, Wang, Dali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330387/ https://www.ncbi.nlm.nih.gov/pubmed/32642118 http://dx.doi.org/10.21037/jtd.2020.04.41 |
Ejemplares similares
-
The Role of CD276 in Cancers
por: Liu, Shengzhuo, et al.
Publicado: (2021) -
Prognostic Significance of CD276 in Non-small Cell Lung Cancer
por: Zhang, Changgong, et al.
Publicado: (2019) -
Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/β-Catenin Signaling
por: Wang, Chengqin, et al.
Publicado: (2021) -
ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4
por: Draheim, K M, et al.
Publicado: (2010) -
Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer
por: Xiong, Ming, et al.
Publicado: (2022)